Novelix Pharmaceuticals Ltd — Others, 14-04-2025: AGM/EGM

Novelix Pharmaceuticals Limited has announced a board meeting on May 9, 2025, to hold an Extraordinary General Meeting (EGM) via video conferencing. The EGM will confirm the appointment of Mr. Lakshman Samala as an Independent Director for a five-year term and Mr. Jivamohan Divakar Valluri as a Non-Executive Non-Independent Director. Both appointments follow prior approval by the Board based on the Nomination and Remuneration Committee's recommendations. This restructuring aims to enhance governance and oversight within the company. Investors may view this as a positive outlook, signaling strengthened leadership and governance standards.